Focus
Antipsychotic Drugs
Researchers Find Ways to Limit Metabolic Side Effects of Antipsychotic Drugs
A new molecule, if administered alongside antipsychotics, can activate dopamine receptors in the pancreas, limiting metabolic disruptions.
|
Study Urges Doctors to Rethink Prescribing Antipsychotics for Dementia Patients
Antipsychotics pose greater health risks than previously understood, leading to severe complications in dementia patients.
|
Remission From ‘Treatment-Resistant’ Schizophrenia Possible With Underutilized Drug: Psychiatrist
Bethany Yeiser is now free of severe schizophrenia symptoms after starting clozapine in 2008, allowing her to graduate college and start the CURESZ Foundation.
|
An Antipsychotic Drug Gets FDA Green Light Despite Fourfold Higher Risk of Death
For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.
|
|
Researchers Find Ways to Limit Metabolic Side Effects of Antipsychotic Drugs
A new molecule, if administered alongside antipsychotics, can activate dopamine receptors in the pancreas, limiting metabolic disruptions.
|
Study Urges Doctors to Rethink Prescribing Antipsychotics for Dementia Patients
Antipsychotics pose greater health risks than previously understood, leading to severe complications in dementia patients.
|
Remission From ‘Treatment-Resistant’ Schizophrenia Possible With Underutilized Drug: Psychiatrist
Bethany Yeiser is now free of severe schizophrenia symptoms after starting clozapine in 2008, allowing her to graduate college and start the CURESZ Foundation.
|
An Antipsychotic Drug Gets FDA Green Light Despite Fourfold Higher Risk of Death
For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.
|
|